These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17098366)

  • 21. Amniotic membrane grafting in the management of acute toxic epidermal necrolysis/Stevens Johnson syndrome.
    Warkad VU; Sahu SK; Das S
    Am J Ophthalmol; 2011 Feb; 151(2):381-2; author reply 382. PubMed ID: 21251496
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxic epidermal necrolysis and Steven Johnson syndrome: 11-years experience and outcome.
    Gravante G; Delogu D; Marianetti M; Trombetta M; Esposito G; Montone A
    Eur Rev Med Pharmacol Sci; 2007; 11(2):119-27. PubMed ID: 17552141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Lee HY; Pang SM; Thamotharampillai T
    J Am Acad Dermatol; 2008 Aug; 59(2):352-3. PubMed ID: 18638633
    [No Abstract]   [Full Text] [Related]  

  • 25. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Koh MJ; Tay YK
    Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Roujeau JC
    Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases].
    Valeyrie-Allanore L; Ingen-Housz-Oro S; Colin A; Thuillot D; Sigal ML; Binhas M
    Ann Dermatol Venereol; 2011 Oct; 138(10):694-7; quiz 692-3, 698. PubMed ID: 21978510
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis in lenalidomide-treated patients.
    Castaneda CP; Brandenburg NA; Bwire R; Burton GH; Zeldis JB
    J Clin Oncol; 2009 Jan; 27(1):156-7. PubMed ID: 19047275
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.
    Guleria VS; Sharda C; Rana T; Sood AK
    Indian J Pharmacol; 2015; 47(4):459-61. PubMed ID: 26288485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
    Abe R
    J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis more common in nonepileptic patients?
    Dhar S; Todi SK
    Dermatology; 1999; 199(2):194. PubMed ID: 10559602
    [No Abstract]   [Full Text] [Related]  

  • 32. Aetiology of drug-induced severe bullous reactions.
    Sen M; George R; Shankar V; Thomas M; Thomas K
    Natl Med J India; 2003; 16(1):50-1. PubMed ID: 12715963
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of toxic epidermal necrolysis syndrome with "disease-modifying" drugs: the controversy goes on.
    Wolf R; Ruocco V; Jablonska S
    Clin Dermatol; 2004; 22(3):267-9. PubMed ID: 15262313
    [No Abstract]   [Full Text] [Related]  

  • 34. [Stevens-Johnson syndrome secondary to carbamazepine mediated by photosensitivity].
    Suárez Moro R; Trapiella Martínez L; Avanzas González E; Salas Puig J; Fernández Fernández C
    An Med Interna; 2000 Feb; 17(2):105-6. PubMed ID: 10829471
    [No Abstract]   [Full Text] [Related]  

  • 35. Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.
    Tebruegge M; Ritz N; Connell T; Curtis N
    Pediatr Infect Dis J; 2008 Nov; 27(11):1041-2. PubMed ID: 18833024
    [No Abstract]   [Full Text] [Related]  

  • 36. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
    Dainichi T; Uchi H; Moroi Y; Furue M
    Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850
    [No Abstract]   [Full Text] [Related]  

  • 37. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
    Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbamazepine-induced Stevens-Johnson syndrome progressing to toxic epidermal necrolysis: a rare clinical image.
    Ralte R; Mendhe D
    Pan Afr Med J; 2024; 47():44. PubMed ID: 38681105
    [No Abstract]   [Full Text] [Related]  

  • 40. A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
    Ugburo AO; Temiye EO; Ilombu CA
    Burns; 2008 Aug; 34(5):637-43. PubMed ID: 18226456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.